Literature DB >> 30350351

Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.

Jarosław Jendrzejewski1,2, Sandya Liyanarachchi1, Andrew Eiterman1, Andrew Thomas1, Huiling He1, Rebecca Nagy1, Leigha Senter1, Krzysztof Sworczak2, Albert de la Chapelle1.   

Abstract

The first two genome wide association studies (GWAS) of papillary thyroid carcinoma (PTC) detected five variants associated with PTC. Two of them (rs944289 and rs116909374) are located at 14q13 making that locus an important target of research into the genetic predisposition to PTC. We aimed at uncovering other variants at 14q13 associated with PTC independently from the GWAS variants. We performed next generation sequencing of the 14q13 region and analyzed the allele frequencies of single nucleotide polymorphisms (SNPs) in n = 90 PTC cases vs. n = 379 EUR controls from the 1,000 Genome Project. The variants associated with PTC were validated in an Ohio cohort of n = 1,216 PTC cases and n = 1,416 controls. Next, we analyzed the association between SNPs and expression of nearby genes and clinical parameters. We showed that rs368187 was associated with PTC (OR = 1.31, p = 2.20 × 10-6 ). Rs1632250, Rs1863347 and rs1755787 showed association with classical PTC (cPTC) (n = 891; OR = 1.24, 2.22 × 10-3 , OR = 1.31, p = 2.15 × 10-4 and OR = 1.24, p = 2.06 × 10-3 , respectively) while variant rs28397092 showed association with follicular variant (n = 243; OR = 1.51, p = 1.36 × 10-3 ). Rs1863347 was associated with suppression of PTCSC3 in unaffected thyroid tissue (p = 0.026). Rs1632250, rs1863347 and rs1755787 showed association with multifocality (OR = 1.85, p = 0.001, OR = 1.98, p = 0.001 and OR = 1.76, p = 0.003 respectively) and N stage (OR = 1.79, p = 0.014, OR = 1.73, p = 0.023 and OR = 1.81, p = 0.013, respectively) in microPTC (n = 328) while rs368187 was associated with M stage (OR = 0.56, p = 0.034) in cPTC. Our results disclose multiple variants associated with PTC and clinical features in the 14q13 superlocus. We suggest that translational genotype/phenotype studies should take into account not only somatic mutations but also germline variants.
© 2018 UICC.

Entities:  

Keywords:  genome-wide association study; next generation sequencing; papillary thyroid carcinoma; rs116909374; rs944289

Mesh:

Year:  2018        PMID: 30350351      PMCID: PMC6294684          DOI: 10.1002/ijc.31933

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  38 in total

1.  Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program.

Authors:  Matthew J Hayat; Nadia Howlader; Marsha E Reichman; Brenda K Edwards
Journal:  Oncologist       Date:  2007-01

2.  A genome-wide association study yields five novel thyroid cancer risk loci.

Authors:  Julius Gudmundsson; Gudmar Thorleifsson; Jon K Sigurdsson; Lilja Stefansdottir; Jon G Jonasson; Sigurjon A Gudjonsson; Daniel F Gudbjartsson; Gisli Masson; Hrefna Johannsdottir; Gisli H Halldorsson; Simon N Stacey; Hannes Helgason; Patrick Sulem; Leigha Senter; Huiling He; Sandya Liyanarachchi; Matthew D Ringel; Esperanza Aguillo; Angeles Panadero; Enrique Prats; Almudena Garcia-Castaño; Ana De Juan; Fernando Rivera; Li Xu; Lambertus A Kiemeney; Gudmundur I Eyjolfsson; Olof Sigurdardottir; Isleifur Olafsson; Hoskuldur Kristvinsson; Romana T Netea-Maier; Thorvaldur Jonsson; Jose I Mayordomo; Theo S Plantinga; Hannes Hjartarson; Jon Hrafnkelsson; Erich M Sturgis; Unnur Thorsteinsdottir; Thorunn Rafnar; Albert de la Chapelle; Kari Stefansson
Journal:  Nat Commun       Date:  2017-02-14       Impact factor: 14.919

3.  The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population.

Authors:  Tatiana I Rogounovitch; Andrey Bychkov; Meiko Takahashi; Norisato Mitsutake; Masahiro Nakashima; Alyaksandr V Nikitski; Tomayoshi Hayashi; Mitsuyoshi Hirokawa; Katsu Ishigaki; Kazuto Shigematsu; Tetiana Bogdanova; Michiko Matsuse; Eijun Nishihara; Shigeki Minami; Kosho Yamanouchi; Masahiro Ito; Takahisa Kawaguchi; Hisayoshi Kondo; Noboru Takamura; Yasuhiro Ito; Akira Miyauchi; Fumihiko Matsuda; Shunichi Yamashita; Vladimir A Saenko
Journal:  Thyroid       Date:  2015-02-05       Impact factor: 6.568

4.  Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.

Authors:  Sandya Liyanarachchi; Anna Wojcicka; Wei Li; Malgorzata Czetwertynska; Elzbieta Stachlewska; Rebecca Nagy; Kevin Hoag; Bernard Wen; Rafal Ploski; Matthew D Ringel; Izabella Kozłowicz-Gudzinska; Wojciech Gierlikowski; Krystian Jazdzewski; Huiling He; Albert de la Chapelle
Journal:  Thyroid       Date:  2013-08-29       Impact factor: 6.568

5.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Authors:  Yuri E Nikiforov; Raja R Seethala; Giovanni Tallini; Zubair W Baloch; Fulvio Basolo; Lester D R Thompson; Justine A Barletta; Bruce M Wenig; Abir Al Ghuzlan; Kennichi Kakudo; Thomas J Giordano; Venancio A Alves; Elham Khanafshar; Sylvia L Asa; Adel K El-Naggar; William E Gooding; Steven P Hodak; Ricardo V Lloyd; Guy Maytal; Ozgur Mete; Marina N Nikiforova; Vania Nosé; Mauro Papotti; David N Poller; Peter M Sadow; Arthur S Tischler; R Michael Tuttle; Kathryn B Wall; Virginia A LiVolsi; Gregory W Randolph; Ronald A Ghossein
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

6.  Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.

Authors:  Alan R Burningham; Jayashree Krishnan; Bruce J Davidson; Matthew D Ringel; Kenneth D Burman
Journal:  Otolaryngol Head Neck Surg       Date:  2005-06       Impact factor: 3.497

Review 7.  The demise of follicular carcinoma of the thyroid gland.

Authors:  V A LiVolsi; S L Asa
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

Review 8.  Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network.

Authors:  Thomas J Giordano
Journal:  Curr Opin Oncol       Date:  2016-01       Impact factor: 3.645

9.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

10.  Association between GWAS-Derived rs966423 Genetic Variant and Overall Mortality in Patients with Differentiated Thyroid Cancer.

Authors:  Michał Świerniak; Anna Wójcicka; Małgorzata Czetwertyńska; Joanna Długosińska; Elżbieta Stachlewska; Wojciech Gierlikowski; Adam Kot; Barbara Górnicka; Łukasz Koperski; Magdalena Bogdańska; Wiesław Wiechno; Krystian Jażdżewski
Journal:  Clin Cancer Res       Date:  2015-10-21       Impact factor: 12.531

View more
  2 in total

1.  Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.

Authors:  Zachary Hurst; Sandya Liyanarachchi; Huiling He; Pamela Brock; Jennifer Sipos; Fadi Nabhan; Electron Kebebew; Patience Green; Gilbert J Cote; Steven Sherman; Christopher J Walker; Yi Seok Chang; Shuai Xue; Brynn Hollingsworth; Wei Li; Luke Genutis; Eric Menq; Albert de la Chapelle; Sissy M Jhiang
Journal:  Thyroid       Date:  2019-02-13       Impact factor: 6.568

2.  Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.

Authors:  Julie Guibon; Pierre-Emmanuel Sugier; Om Kulkarni; Mojgan Karimi; Delphine Bacq-Daian; Céline Besse; Anne Boland; Elisabeth Adjadj; Frédérique Rachédi; Carole Rubino; Constance Xhaard; Claire Mulot; Pierre Laurent-Puig; Anne-Valérie Guizard; Claire Schvartz; Rosa Maria Ortiz; Yan Ren; Evgenia Ostroumova; Jean-François Deleuze; Marie-Christine Boutron-Ruault; Ausrele Kesminiene; Florent De Vathaire; Pascal Guénel; Fabienne Lesueur; Thérèse Truong
Journal:  Oncotarget       Date:  2021-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.